Treadmill exercise testing is widely available and has been used for more than half a century for the evaluation of exercise related symptoms and assessment of myocardial ischemia. Over the years, additional use and goals for exercise testing have been evolved, including exercise prescription, evaluation of physical capacity and effort tolerance, as well as assessment of arrhythmias, chronotropic competence, and therapeutic response to medications and implanted device interventions.1 With time, it became apparent, that apart from the diagnostic value of the exercise electrocardiogram (ECG) for identification of coronary artery disease and assessment of its severity, aerobic exercise capacity has significant prognostic importance and may aid in the assessment of future cardiovascular risk. The association between low exercise capacity and reduced long-term survival was shown to be independent of traditional risk factors.2 A single measurement of fitness significantly improves classification of both short-term and long-term (25-year) risk for cardiovascular disease mortality when added to traditional risk factors.3 In a meta-analysis of 33 eligible studies of healthy populations a higher level of maximal aerobic capacity amounting to one metabolic equivalent (MET) increase was associated with a 13% risk reduction in all-cause mortality.